Sarepta Therapeutics (SRPT) Current Deferred Revenue (2010 - 2026)
Sarepta Therapeutics (SRPT) reported Current Deferred Revenue of $110.13 million for Q2 2026, down 72.1% from $395.43 million a year earlier and down 5.1% from the prior quarter.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Current Deferred Revenue (2010 - 2026) Analysis & Trends
At the end of FY2025, Sarepta Therapeutics posted Current Deferred Revenue of $443.4 million, up 240.4% from FY2024.
- Current Deferred Revenue has a five-year compound annual growth rate of 37.8% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $130.26 million in FY2024 (+158.4%), $50.42 million in FY2023 (-43.5%), $89.24 million in FY2022 (unchanged) and $89.24 million in FY2021 (unchanged).
- The Q2 2026 figure ranks as the lowest quarterly Current Deferred Revenue since Q1 2025.
- Year over year, Current Deferred Revenue gained in six of the last eight quarters, with growth averaging 174.5%.
- The high point for year-over-year Current Deferred Revenue in five years was Q3 2024 (growth of 464.6%); the low point was Q3 2023 (a decline of 74.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $116.04 million (Q1 2026), $443.4 million (Q4 2025) and $485.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Sarepta Therapeutics | 1.96 Bn | -1.27 Bn | 251.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110.13 Mn |
| Mar 31, 2026 | 116.04 Mn |
| Dec 31, 2025 | 443.40 Mn |
| Sep 30, 2025 | 485.45 Mn |
| Jun 30, 2025 | 395.43 Mn |
| Mar 31, 2025 | 44.86 Mn |
| Dec 31, 2024 | 130.26 Mn |
| Sep 30, 2024 | 127.00 Mn |
| Jun 30, 2024 | 122.04 Mn |
| Mar 31, 2024 | 112.00 Mn |
| Dec 31, 2023 | 50.42 Mn |
| Sep 30, 2023 | 22.49 Mn |
| Jun 30, 2023 | 44.99 Mn |
| Mar 31, 2023 | 67.24 Mn |
| Dec 31, 2022 | 89.24 Mn |
| Sep 30, 2022 | 89.24 Mn |
| Jun 30, 2022 | 89.24 Mn |
| Mar 31, 2022 | 89.24 Mn |
| Dec 31, 2021 | 89.24 Mn |
| Sep 30, 2021 | 89.24 Mn |
API Access
Sarepta Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();